Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Vertex Pharmaceuticals Inc. buy Wolfe Research

Start price
€393.55
15.02.24 / 50%
Target price
€478.13
15.02.25
Performance (%)
-0.24%
Price
€392.60
10.05.24
Summary
This prediction is currently active. Since the start of the prediction for Vertex Pharmaceuticals Inc. the price has only changed by -0.24%. This prediction currently runs until 15.02.25. The prediction end date can be changed by Wolfe_Research at any time. Wolfe_Research has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Vertex Pharmaceuticals Inc. 5.368% 5.368%
iShares Core DAX® 4.094% 4.888%
iShares Nasdaq 100 1.424% -0.445%
iShares Nikkei 225® -1.572% -4.911%
iShares S&P 500 1.822% 0.776%

Comments by Wolfe_Research for this prediction

In the thread Vertex Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) -0.24%
Target price 478.126
Change
Ends at 15.02.25

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $515.00 price target on the stock.
Ratings data for VRTX provided by MarketBeat